Cargando…
SOX1 acts as a tumor hypnotist rendering nasopharyngeal carcinoma cells refractory to chemotherapy
SOX1, a well-known tumor suppressor, delays malignant progression in most cancer types. However, high expression of SOX1 in late-stage head and neck squamous cell carcinoma leads to poor prognosis. In this study, we show that SOX1 induces nasopharyngeal carcinoma (NPC) cells to enter a quiescent sta...
Autores principales: | Lei, Xin-Xing, Wang, Shu-Lan, Xia, Ying, Yan, Min, He, Bin, Wang, Bo, Long, Zi-Jie, Liu, Quentin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300072/ https://www.ncbi.nlm.nih.gov/pubmed/37369660 http://dx.doi.org/10.1038/s41420-023-01479-x |
Ejemplares similares
-
SOX1 promotes differentiation of nasopharyngeal carcinoma cells by activating retinoid metabolic pathway
por: Lei, Xin-Xing, et al.
Publicado: (2020) -
MicroRNA-212 inhibits the metastasis of nasopharyngeal carcinoma by targeting SOX4
por: Jiang, Chengyi, et al.
Publicado: (2017) -
[Retracted] MicroRNA‑212 inhibits the metastasis of nasopharyngeal carcinoma by targeting SOX4
por: Jiang, Chengyi, et al.
Publicado: (2023) -
SOX1 down-regulates β-catenin and reverses malignant phenotype in nasopharyngeal carcinoma
por: Guan, Zhong, et al.
Publicado: (2014) -
Super-enhancer driven SOX2 promotes tumor formation by chromatin re-organization in nasopharyngeal carcinoma
por: Liu, Shang-Xin, et al.
Publicado: (2023)